Development of a genomic metric that can be rapidly used to predict clinical outcome in severely injured trauma patients

Critical Care Medicine

Volumn 41, Issue 5, 2013, Pages 1175-1185

  Cuenca, Alex G ^a   Gentile, Lori F ^a   Lopez, M Cecilia ^a   Ungaro, Ricardo ^a   Liu, Huazhi ^a   Xiao, Wenzhong ^b   Seok, Junhee ^b   Mindrinos, Michael N ^b   Ang, Darwin ^a   Baslanti, Tezcan Ozrazgat ^a   Bihorac, Azra ^a   Efron, Philip A ^a   Cuschieri, Joseph ^c   Warren, H Shaw ^d   Tompkins, Ronald G ^d   Maier, Ronald V ^c   Baker, Henry V ^a   Moldawer, Lyle L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

blunt trauma; genomic composite score; microarray; validation

Indexed keywords

MESSENGER RNA;

ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION II; ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; GENE EXPRESSION; GENOMICS; HUMAN; INJURY; INJURY SCALE; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; APACHE; CAUSE OF DEATH; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HOSPITAL MORTALITY; HUMANS; INJURY SEVERITY SCORE; LEUKOCYTES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TIME FACTORS; TRAUMA CENTERS; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84876666943     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318277131c     Document Type: Article

References (29)

1. Probst C, Pape HC, Hildebrand F, et al: 30 years of polytrauma care: An analysis of the change in strategies and results of 4849 cases treated at a single institution. Injury 2009; 40:77-83
2. Cothren CC, Moore EE, Hedegaard HB, et al: Epidemiology of urban trauma deaths: A comprehensive reassessment 10 years later. World J Surg 2007; 31:1507-1511
3. Bamvita JM, Bergeron E, Lavoie A, et al: The impact of premorbid conditions on temporal pattern and location of adult blunt trauma hospital deaths. J Trauma 2007; 63:135-141
4. Demetriades D, Murray J, Charalambides K, et al: Trauma fatalities: Time and location of hospital deaths. J Am Coll Surg 2004; 198:20-26
5. Bone RC, Balk RA, Fein AM, et al: A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: Results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med 1995; 23:994-1006
6. Fisher CJ Jr; Slotman GJ, Opal SM, et al: IL-1RA Sepsis Syndrome Study Group: Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebo-controlled multicenter trial. Crit Care Med 1994; 22:12-21
7. Abraham E, Glauser M P, Butler T, et al: p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group. JAMA 1997; 277:1531-1538
8. Abraham E, Laterre PF, Garbino J, et al: Lenercept Study Group: Lener-cept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1, 342 patients. Crit Care Med 2001; 29:503-510
9. Oberholzer A, Souza SM, Tschoeke SK, et al: Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 2005; 23:488-493
10. de Pablo R, Monserrat J, Reyes E, et al: Mortality in patients with septic shock correlates with anti-infammatory but not proinfamma-tory immunomodulatory molecules. J Intensive Care Med 2011; 26:125-132
11. Hoffmann U, Bertsch T, Dvortsak E, et al: Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: Prognostic value of TIMP-1 in severe sepsis. Scand J Infect Dis 2006; 38:867-872
12. Pruitt JH, Welborn MB, Edwards PD, et al: Increased soluble interleu-kin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood 1996; 87:3282-3288
13. Xiao W, Mindrinos MN, Seok J, et al: Infammation and Host Response to Injury Large-Scale Collaborative Research Program: A genomic storm in critically injured humans. J Exp Med 2011; 208:2581-2590
14. Warren HS, Elson CM, Hayden DL, et al: Infammation and Host Response to Injury Large Scale Collaborative Research Program: A genomic score prognostic of outcome in trauma patients. Mol Med 2009; 15:220-227
15. Desai KH, Tan CS, Leek JT, et al: Infammation and the Host Response to Injury Large-Scale Collaborative Research Program: Dissecting infam-matory complications in critically injured patients by within-patient gene expression changes: A longitudinal clinical genomics study. PLoS Med 2011; 8:e1001093
16. Minei JP, Cuschieri J, Sperry J, et al: Infammation and the Host Response to Injury Collaborative Research Program: The changing pattern and implications of multiple organ failure after blunt injury with hemorrhagic shock. Crit Care Med 2012; 40:1129-1135
17. Feezor RJ, Baker HV, Mindrinos M, et al: Infammation and Host Response to Injury, Large-Scale Collaborative Research Program: Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol Genomics 2004; 19:247-254
18. Cobb J P, Mindrinos MN, Miller-Graziano C, et al: Infammation and Host Response to Injury Large-Scale Collaborative Research Program: Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci USA 2005; 102:4801-4806
19. Zhou B, Xu W, Herndon D, et al: Infammation and Host Response to Injury Program: Analysis of factorial time-course microarrays with application to a clinical study of burn injury. Proc Natl Acad Sci USA 2010; 107:9923-9928
20. Leek JT, Monsen E, Dabney AR, et al: EDGE: Extraction and analysis of differential gene expression. Bioinformatics 2006; 22:507-508
21. Geiss GK, Bumgarner RE, Birditt B, et al: Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 2008; 26:317-325
22. Cuschieri J, Johnson JL, Sperry J, et al: Infammation and Host Response to Injury, Large Scale Collaborative Research Program: Benchmarking outcomes in the critically injured trauma patient and the effect of implementing standard operating procedures. Ann Surg 2012; 255:993-999
23. Ciesla DJ, Moore EE, Johnson JL, et al: A 12-year prospective study of postinjury multiple organ failure: Has anything changed? Arch Surg 2005; 140:432-8; discussion 438
24. Pfeifer R, Tarkin IS, Rocos B, et al: Patterns of mortality and causes of death in polytrauma patients-has anything changed? Injury 2009; 40:907-911
25. Marshall JC: Such stuff as dreams are made on: Mediator-directed therapy in sepsis. Nat Rev Drug Discov 2003; 2:391-405
26. Frantz S: An array of problems. Nat Rev Drug Discov 2005; 4:362-363
27. Sethu P, Anahtar M, Moldawer LL, et al: Continuous fow microfuidic device for rapid erythrocyte lysis. Anal Chem 2004; 76:6247-6253
28. Russom A, Sethu P, Irimia D, et al: Infammation and Host Response to Injury Large Scale Collaborative Research Program: Microfuidic leukocyte isolation for gene expression analysis in critically ill hospitalized patients. Clin Chem 2008; 54:891-900
29. Turina M, Dickinson A, Gardner S, et al: Monocyte HLA-DR and inter-feron-gamma treatment in severely injured patients-A critical reappraisal more than a decade later. J Am Coll Surg 2006; 203:73-81